Compounds for enzyme inhibition
US8609654B1 · kind B1 · utility
8Cited by
70References
60Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Aug 16, 2013 |
| Grant date | Dec 17, 2013 |
| Priority date | — |
| Expiry date | Aug 16, 2033 |
Classification
- Technology area (CPC Y)Emerging Cross-Sectional Technologies
- CPC primaryY02A50/30
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
One aspect of the invention relates to inhibitors that preferentially inhibit immunoproteasome activity over constitutive proteasome activity. In certain embodiments, the invention relates to the treatment of immune related diseases, comprising administering a compound of the invention. In certain embodiments, the invention relates to the treatment of cancer, comprising administering a compound of the invention.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.